Exploration of a novel therapeutic approach targeting type 1 diabetes using the filarial derived WbL2 and other immunomodulatory proteins

Abstract

newline

Description

Keywords

Citation

item.page.endorsement

item.page.review

item.page.supplemented

item.page.referenced